AC Immune S.A.
ACIU · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $161,993 | $165,995 | $269,751 |
| - Cash | $27,741 | $25,722 | $19,960 | $36,275 |
| + Debt | $3,616 | $4,919 | $5,175 | $5,427 |
| Enterprise Value | – | $141,190 | $151,210 | $238,903 |
| Revenue | $939 | $1,306 | $990 | $1,137 |
| % Growth | -28.1% | 31.9% | -12.9% | – |
| Gross Profit | $939 | $1,306 | $990 | $1,137 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$15,518 | -$20,516 | -$18,363 | -$15,235 |
| % Margin | -1,652.6% | -1,570.9% | -1,854.8% | -1,339.9% |
| Net Income | -$15,858 | -$21,189 | -$19,029 | -$15,797 |
| % Margin | -1,688.8% | -1,622.4% | -1,922.1% | -1,389.4% |
| EPS Diluted | -0.16 | -0.21 | -0.19 | -0.15 |
| % Growth | 23.8% | -10.5% | -26.7% | – |
| Operating Cash Flow | -$18,340 | -$15,598 | -$18,816 | $5,934 |
| Capital Expenditures | -$58 | -$373 | -$362 | -$90 |
| Free Cash Flow | -$18,398 | -$15,971 | -$19,178 | $5,844 |